Document is current

Article History

Received: 28 December 2023

Accepted: 29 July 2024

First Online: 8 August 2024

Declarations

:

: All participants provided informed consent prior to completing the survey and could withdraw at any time, and participants who completed the entire survey received a modest monetary incentive. The study protocol was submitted to the Western Institutional Review Board for ethical approval and was determined to qualify for exemption status because sufficient protections were in place to protect the privacy of subjects and to maintain the confidentiality of data. The study and data accumulation were in conformity with all country, federal, or state laws, and the study adhered to the tenets of the Declaration of Helsinki.

: Not applicable.

: CC is a speaker for Novo Nordisk, Lilly, and Boeringher Ingelheim (BI). He serves on the advisory board and as a consultant for Novo Nordisk, Lilly, BI and Sanofi. MM is a Consultant/Advisory Board Member for Novo Nordisk and Boehringer Ingelheim. JB is a consultant to Abbott, American Regent, Amgen, Applied Therapeutic, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Edwards, Element Science, Innolife, Impulse Dynamics, Imbria, Inventiva, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Roche, Sequana, SQ Innovation, 3live, and Vifor. AH and AS are employees of and shareholders in Novo Nordisk Inc. (Plainsboro, NJ, USA).SJS reports receiving research grants from the National Institutes of Health (U54 HL160273, R01 HL127028, R01 HL140731, and R01 HL149423), AstraZeneca, Corvia Medical, and Pfizer; and consulting fees from Abbott, AstraZeneca, Alleviant, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer-Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Imara, Impulse Dynamics, Intellia, Ionis, Lilly, Merck, Metabolic Flux, MyoKardia, NGM Biopharmaceuticals, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sardocor, Shifamed, Tenax, Tenaya, Ultromics, and United Therapeutics.